Antineoplastic Agents. 606. the Betulastatins

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The medicinal potential of the plant pentacyclic triterpene betulin has generated long-term interest focused on various SAR research avenues. The present approach was based on producing further analogues (chimeras) arising from a studied modification of betulin bonded to the Dov-Val-Dil-Dap unit of the powerful anticancer drug dolastatin 10, which provided betulastatins 1 (7b), 2 (11b), 3 (16b), and 4 (18b). Betulastatin 1, 2, and 4 exhibited modest levels of cancer cell growth inhibition against six cancer cell lines. Betulastatin 3 proved to be the most potent cancer cell growth inhibitor (GI50 0.01 μg/mL) and seems worthy of further development, as the presumed mixture of anticancer mechanisms of action may prove to be useful.

Original languageEnglish (US)
Pages (from-to)458-464
Number of pages7
JournalJournal of Natural Products
Volume81
Issue number3
DOIs
StatePublished - Mar 23 2018

Fingerprint

dolastatin 10
Antineoplastic Agents
Pentacyclic Triterpenes
Growth Inhibitors
Cell growth
Neoplasms
Cells
Medicinal Plants
Pharmaceutical Preparations
Cell Line
Growth
Research
betulin

ASJC Scopus subject areas

  • Analytical Chemistry
  • Molecular Medicine
  • Pharmacology
  • Pharmaceutical Science
  • Drug Discovery
  • Complementary and alternative medicine
  • Organic Chemistry

Cite this

Antineoplastic Agents. 606. the Betulastatins. / Pettit, George; Melody, Noeleen; Chapuis, Jean.

In: Journal of Natural Products, Vol. 81, No. 3, 23.03.2018, p. 458-464.

Research output: Contribution to journalArticle

@article{ac715d5a11854dd8bf88251f7e8b718b,
title = "Antineoplastic Agents. 606. the Betulastatins",
abstract = "The medicinal potential of the plant pentacyclic triterpene betulin has generated long-term interest focused on various SAR research avenues. The present approach was based on producing further analogues (chimeras) arising from a studied modification of betulin bonded to the Dov-Val-Dil-Dap unit of the powerful anticancer drug dolastatin 10, which provided betulastatins 1 (7b), 2 (11b), 3 (16b), and 4 (18b). Betulastatin 1, 2, and 4 exhibited modest levels of cancer cell growth inhibition against six cancer cell lines. Betulastatin 3 proved to be the most potent cancer cell growth inhibitor (GI50 0.01 μg/mL) and seems worthy of further development, as the presumed mixture of anticancer mechanisms of action may prove to be useful.",
author = "George Pettit and Noeleen Melody and Jean Chapuis",
year = "2018",
month = "3",
day = "23",
doi = "10.1021/acs.jnatprod.7b00536",
language = "English (US)",
volume = "81",
pages = "458--464",
journal = "Journal of Natural Products",
issn = "0163-3864",
publisher = "American Chemical Society",
number = "3",

}

TY - JOUR

T1 - Antineoplastic Agents. 606. the Betulastatins

AU - Pettit, George

AU - Melody, Noeleen

AU - Chapuis, Jean

PY - 2018/3/23

Y1 - 2018/3/23

N2 - The medicinal potential of the plant pentacyclic triterpene betulin has generated long-term interest focused on various SAR research avenues. The present approach was based on producing further analogues (chimeras) arising from a studied modification of betulin bonded to the Dov-Val-Dil-Dap unit of the powerful anticancer drug dolastatin 10, which provided betulastatins 1 (7b), 2 (11b), 3 (16b), and 4 (18b). Betulastatin 1, 2, and 4 exhibited modest levels of cancer cell growth inhibition against six cancer cell lines. Betulastatin 3 proved to be the most potent cancer cell growth inhibitor (GI50 0.01 μg/mL) and seems worthy of further development, as the presumed mixture of anticancer mechanisms of action may prove to be useful.

AB - The medicinal potential of the plant pentacyclic triterpene betulin has generated long-term interest focused on various SAR research avenues. The present approach was based on producing further analogues (chimeras) arising from a studied modification of betulin bonded to the Dov-Val-Dil-Dap unit of the powerful anticancer drug dolastatin 10, which provided betulastatins 1 (7b), 2 (11b), 3 (16b), and 4 (18b). Betulastatin 1, 2, and 4 exhibited modest levels of cancer cell growth inhibition against six cancer cell lines. Betulastatin 3 proved to be the most potent cancer cell growth inhibitor (GI50 0.01 μg/mL) and seems worthy of further development, as the presumed mixture of anticancer mechanisms of action may prove to be useful.

UR - http://www.scopus.com/inward/record.url?scp=85044547023&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044547023&partnerID=8YFLogxK

U2 - 10.1021/acs.jnatprod.7b00536

DO - 10.1021/acs.jnatprod.7b00536

M3 - Article

VL - 81

SP - 458

EP - 464

JO - Journal of Natural Products

JF - Journal of Natural Products

SN - 0163-3864

IS - 3

ER -